Reduced Light BrightnessNCT07104071
Effect of Light Brightness on Well-being, Breastfeeding Motivation, and Psychological Well-being of Postpartum Mothers: A Randomized Placebo-controlled Trial
A study testing reduced light brightness in people with Reduced Light Brightness, run by Emine Yıldırım.
Trial summary
This study aims to determine the effects of light brightness on postpartum mothers' well-being, breastfeeding motivation, and psychological well-being. This study is a randomized, placebo-controlled study. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Reduced Light Brightness
- What is being tested?
- reduced light brightness
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- No sites listed yet
- Study dates
- 15 Aug 2025to 23 Aug 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- being postpartum mothers.
Who cannot join
- having communication problems
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
This study aims to determine the effects of light brightness on postpartum mothers' well-being, breastfeeding motivation, and psychological well-being.
This study is a randomized, placebo-controlled study.
- Conditions
- Reduced Light Brightness
- Being tested
- reduced light brightness
- Keywords
- peaces, well-being, breastfeeding
- Medical subject headings
- Breast Feeding
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
reduced light brightnessOther
reduced light brightness
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | reduced light brightness Receives: Other: reduced light brightness |
| control group | No intervention | No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
peace scala
peace
Measured: 12 hours
well-being scala
well-being
Measured: 12 hours
breastfeeding motivation scala
breastfeeding motivation
Measured: 12 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2025
- Study start15 Aug 2025 (estimated)
- Primary completion22 Aug 2025 (estimated)
- Study completion23 Aug 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Reduced Light BrightnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 42 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Emine Yıldırım
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Emine Yıldırım, Osmaniye Korkut Ata University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07104071
- Sponsor's protocol ID
- 131313
- Status last verified
- Jul 2025
- First submitted
- 29 Jul 2025
- Last updated
- 5 Aug 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Light Brightness on Well-being, Breastfeeding Motivation, and Psychological Well-being of Postpartum Mothers: A Randomized Placebo-controlled Trial
- ClinicalTrials.gov ID
- NCT07104071
- Acronym / sponsor ID
- 131313
- Conditions
- Reduced Light Brightness
- Keywords
- peaces, well-being, breastfeeding
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 42 participants (estimated)
- Lead sponsor
- Emine YıldırımUniversity, hospital or other
- Study start
- 15 Aug 2025 (estimated)
- Primary completion
- 22 Aug 2025 (estimated)
- Study completion
- 23 Aug 2025 (estimated)
- First posted
- 5 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to determine the effects of light brightness on postpartum mothers' well-being, breastfeeding motivation, and psychological well-being.
This study is a randomized, placebo-controlled study.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Other: reduced light brightnessreduced light brightness |
| control group | No intervention | –No intervention |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- being postpartum mothers.
Key exclusion criteria (1 listed)
- having communication problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| reduced light brightnessreduced light brightness | Other | Intervention group |
Primary outcome
peace scala
Time frame: 12 hours
peace
well-being scala
Time frame: 12 hours
well-being
breastfeeding motivation scala
Time frame: 12 hours
breastfeeding motivation
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2025.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing reduced light brightness in people with Reduced Light Brightness, run by Emine Yıldırım.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Emine E Yıldırım, Assistant Professor (+905066268672, eminekucukyildirim@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
peace scala (time frame: 12 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2025; AzTrials last refreshed its copy on 7 Nov 2026.